Company News & Publications

Upcoming Conferences

BIO-Europe 2015
Munich, Germany

» Visit website

nov, 2015
2-4

 

 

ICAB 2015
Budapest, Hungary

» Visit website

NOV, 2015
14


Latest events

BIO International Convention
Philadelphia, PA, USA

» Visit website

june, 2015
15-19

Formulation & Drug Delivery Congress

London, UK
Location

» Visit website

May, 20115
18-19

 

6th Annual Global Drug Delivery & Formulation Summit
Düsseldorf, Germany
» Visit website

FEB, 2015
09-11

 

BIO Europe
Frankfurt, Germany
» Visit website

Nov, 2014
03-05

 

Jun, 2014
23-26

Bio International Conveniton
San Diego, CA, USA
» Visit website


May, 2014
28-29

BioForum
Lodz, Poland
» Visit website


May, 2014
21-22

2nd Annual Formulation and Drug Delivery
Boston, MA, USA
» Visit website


May, 2014
19-21

4th International Workshop on A to Z Bioequivalence Bioanalysis, Dissolution and Biosimilarity
Budapest, Hungary
» Visit website


PBP World Meeting
Lisbon, Portugal
» Visit website

Mar, 2014
31-03

World Drug Delivery and Formulation 2014
Berlin, Germany
» Visit website

Feb, 2014
17-19

JP Morgan 32nd Annual Healthcare Conference
San Francisco, CA, USA
» Visit website

Jan, 2014
13-16


 

News & Press releases

Quotient Clinical begins prostate cancer project for Druggability Technologies

June 23, 2015 - Quotient Clinical, the Translational Pharmaceutics® Company, initiates a new RapidFACT program for Druggability Technologies (DRGT) for evaluating enhanced formulations of abiratone acetate.

» Read more



Gabor Heltovics, CEO to present at Formulation & Drug Delivery Congress, London, UK.

Join our sesseion on Day 1 , Optimising Formulation steam, 12.20 -  12.50 pm. and learn more on our latest achievments.

 

 

Druggability Technologies enters into a strategic collaboration with Bayer HealthCare

DRGT signs a broad collaboration agreement with Bayer HealthCare to leverage DRGT’s Super-API Technology to accelerate the discovery and development of novel drugs.

» Read more


Druggability Technologies Announces Financial Investment by SPCH

Druggability Technologies Holdings Limited (DRGT), a privately held biotechnology platform company, announced today that it has completed an initial round of financing totaling $4,000,000.

» Read more


Publications

Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow method

Tamás Solymosi, Réka Angi, Orsolya Basa-Dénes, Soma Ránky , Zsolt Ötvös, Hristos Glavinas, Genovéva Filipcsei  and Gábor Heltovics

» Read publication

 

Novel Continuous flow technology for the development of nanostructured Aprepitant formulation with improved pharmacocinetics properties

Réka Angi, Tamás Solymosi, Zsolt Ötvös, Betti Ordasi, Hristos Glavinas, Genovéva Filipcsei, Gábor Heltovics and Ferenc Darvas

» Read publication

 

Flow chemistry for nanotechnology, Flow chemistry graduate textbook, Chapter 6, Vol.2.: Applications,  Ed. by Darvas, Ferenc / Hessel, Volker / Dorman, György, Walter de Gruyter, 2014, pp 161-187

Genovéva Filipcsei, Zsolt Ötvös, Réka Angi and Ferenc Darvas

» Read publication